VistaGen Therapeutics Company Presentation

Neuroactive Nasal Spray Stand-alone Treatment for Adults with Major Depressive Disorder ƒ Odorless synthetic neuroactive nasal spray ƒ Non-systemic ƒ Successful Phase 2A in MDD completed ƒ Potential rapid-onset antidepressant effects ƒ Exceptional safety in all studies to date ƒ Preparing for Phase 2B in MDD Potential rapid-onset antidepressant without side effects and safety concerns of ketamine-based therapy LOOKING BEYOND THE STANDARD OF CARE FOR ANXIETY, DEPRESSION AND OTHER CNS DISORDERS